Workweek January 9, 2024
Blake Madden

agilon’s no-good, very bad start to 2024

agilon kicked off the year in the worst possible way for the Medicare-focused enablement firm, announcing a huge cut to its expected financial results. Meanwhile, it also announced the retiring of its CFO on the same day. Goes without saying, but announcing a CFO transition the same day your company slashes your projected earnings is a recipe for disaster, as noted by the utter destruction of shareholder value, down 30% on the day:

As it turns out, agilon – a ~$5B enterprise (well, now $3.2B) – was flying blind for much of 2023 with lagging claims data and a poor analytics infrastructure:

  • ‘During 2023, agilon health experienced an increase in medical expenses...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage
Growth in Medicare Advantage Raises Concerns
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future
Medicare Privatization Is Breaking the Bank

Share This Article